Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC
Clinical trial NCT00522249 · TERMINATED
Trial details
- NCT number
- NCT00522249
- Sponsor
- The Methodist Hospital Research Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.